跳至主要内容
临床试验/JPRN-UMIN000011131
JPRN-UMIN000011131尚未招募未知

A study to evaluate the effect of cilostazol after endovascular therapy for SFA lesions - A study to evaluate the effect of cilostazol after endovascular therapy for SFA lesions

Saiseikai yokohama city eastern hospital0 个研究点目标入组 100 人开始时间: 2013年7月6日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patient criteria Patients who meet any of the following criteria should be excluded from the study: 1.Patients with or at risk of hemorrhagic complications or patients with bleeding* tendency *Bleeding such as hemophilia, capillary fragility, intracranial hemorrhage, gastrointestinal hemorrhage, urinary tract hemorrhage, hemoptysis, or vitreous hemorrhage may be aggravated. 2.Pregnant or potentially pregnant women 3.Patients with acute lower limb ischemia 4. Patients who are not eligible for the study in the opinion of the attending physician. Lesion criteria Lesions that meet any of the following criteria should be excluded from the study: 1.Remnant inflow (aorta-iliac artery lesion) 2.Severe calcification (lesions not expected to be appropriately expanded) 3.No arterial runoff below the knee

研究者

发起方
Saiseikai yokohama city eastern hospital

相似试验